Tech Company Financing Transactions
Intabio Funding Round
Intabio, based in Newark, secured $2 million from 5 Prime Ventures, private investors and Morgan Noble Healthcare Partners.
Transaction Overview
Company Name
Announced On
9/15/2017
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Seed
Investors
5 Prime Ventures (Lead Investor) (Jenny Rooke)
private investors (Michael Finney)
private investors (William Hyun)
Proceeds Purpose
The funding will enable us to place systems with biopharma customers in early 2018.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
39655 Eureka Dr.
Newark, CA 94560
USA
Newark, CA 94560
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Intabio provides an analytical platform to transform and accelerate the development of biotherapeutic drugs by enabling early product quality characterization and producing profound efficiency gains across all stages of biopharmaceutical development and manufacturing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lena Wu
Chief Technical Officer
Erik Gentalen
VP - Marketing
Walter Ausserer
VP - Product Management
Ian Walton
Browse more venture capital transactions:
Prev: 9/15/2017: ExecThread venture capital transaction
Next: 9/15/2017: Gemr venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs